• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与肝癌风险:基于对日本人群流行病学证据的系统评价

Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese.

作者信息

Tanaka Keitaro, Tsuji Ichiro, Wakai Kenji, Nagata Chisato, Mizoue Tetsuya, Inoue Manami, Tsugane Shoichiro

机构信息

Department of Preventive Medicine, Saga University, Japan.

出版信息

Jpn J Clin Oncol. 2006 Jul;36(7):445-56. doi: 10.1093/jjco/hyl040. Epub 2006 Jun 16.

DOI:10.1093/jjco/hyl040
PMID:16782973
Abstract

BACKGROUND

Emerging epidemiologic data suggest that cigarette smoking may increase the risk of primary liver cancer. We evaluated this association based on a systematic review of epidemiologic evidence among Japanese populations.

METHODS

Original data were obtained from MEDLINE searches using PubMed, complemented with manual searches. The evaluation was performed in terms of the magnitude of association ('strong', 'moderate', 'weak' or 'no association') in each study and the strength of evidence ('convincing', 'probable', 'possible' or 'insufficient'), together with biological plausibility as previously done by the International Agency for Research on Cancer.

RESULTS

A total of 12 cohort studies and 11 case-control studies were identified. Nine cohort studies (two with adjustment for hepatitis B and C virus infections and seven without it) reported weak to strong positive associations between smoking and liver cancer, with dose-response relationships shown in three studies. Five case-controls studies (three with the virus adjustment and two without it) demonstrated such positive associations, with a dose-response relationship shown in only one study, while in six case-control studies, the observed associations were judged to be of the lowest magnitude or inverse due to the lack of any dose-response relationship.

CONCLUSION

We conclude that cigarette smoking 'probably' increases the risk of primary liver cancer among the Japanese. Potential confounding by hepatitis virus infection and virus-smoking interactions need to be addressed in future studies.

摘要

背景

新出现的流行病学数据表明,吸烟可能会增加原发性肝癌的风险。我们基于对日本人群流行病学证据的系统评价,对这种关联进行了评估。

方法

原始数据通过使用PubMed在MEDLINE中检索获得,并辅以手工检索。评估是根据每项研究中关联的程度(“强”、“中度”、“弱”或“无关联”)和证据的强度(“令人信服”、“很可能”、“可能”或“不足”),以及如国际癌症研究机构之前所做的那样,结合生物学合理性来进行的。

结果

共识别出12项队列研究和11项病例对照研究。9项队列研究(2项对乙型和丙型肝炎病毒感染进行了校正,7项未校正)报告吸烟与肝癌之间存在弱至强的正相关,3项研究显示了剂量反应关系。5项病例对照研究(3项对病毒进行了校正,2项未校正)显示了这种正相关,仅1项研究显示了剂量反应关系,而在6项病例对照研究中,由于缺乏任何剂量反应关系,观察到的关联被判定为关联程度最低或呈负相关。

结论

我们得出结论,吸烟“很可能”会增加日本人患原发性肝癌的风险。未来的研究需要解决肝炎病毒感染和病毒-吸烟相互作用可能造成的混杂问题。

相似文献

1
Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese.吸烟与肝癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 Jul;36(7):445-56. doi: 10.1093/jjco/hyl040. Epub 2006 Jun 16.
2
Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.吸烟与结直肠癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 Jan;36(1):25-39. doi: 10.1093/jjco/hyi207. Epub 2006 Jan 19.
3
Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population.吸烟与乳腺癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 Jun;36(6):387-94. doi: 10.1093/jjco/hyl031. Epub 2006 Jun 9.
4
Alcohol drinking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.饮酒与结直肠癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2006 Sep;36(9):582-97. doi: 10.1093/jjco/hyl069. Epub 2006 Jul 26.
5
Heated tobacco products for smoking cessation and reducing smoking prevalence.加热烟草制品戒烟和降低吸烟率。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2.
6
Alcohol drinking and lung cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.饮酒与肺癌风险:基于对日本人群流行病学证据的系统评价
Jpn J Clin Oncol. 2007 Mar;37(3):168-74. doi: 10.1093/jjco/hyl146. Epub 2007 Mar 1.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Burden of cancer attributable to tobacco smoke in Japan in 2015.2015年日本因吸烟导致的癌症负担。
GHM Open. 2021 Dec 31;1(2):43-50. doi: 10.35772/ghmo.2021.01013.
2
Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinoma.香港肝癌巴塞罗那临床肝癌分期系统在肝细胞癌中的预后性能。
BMC Gastroenterol. 2024 Sep 18;24(1):318. doi: 10.1186/s12876-024-03387-5.
3
Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma.
乙肝病毒所致肝细胞癌循环肿瘤DNA中TP53和CTNNB1基因热点突变的评估
Front Genet. 2023 Aug 1;14:1235260. doi: 10.3389/fgene.2023.1235260. eCollection 2023.
4
Tobacco, Cigarettes, and the Liver: The Smoking Gun.烟草、香烟与肝脏:确凿证据
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):700-712. doi: 10.1016/j.jceh.2021.07.016. Epub 2021 Aug 10.
5
Chemical Risk Factors of Primary Liver Cancer: An Update.原发性肝癌的化学危险因素:最新进展
Hepat Med. 2021 Jan 5;12:179-188. doi: 10.2147/HMER.S278070. eCollection 2020.
6
Responses of smoking and nonsmoking cancer patients to drug treatment: A protocol for systematic review and meta-analysis.吸烟与不吸烟癌症患者对药物治疗的反应:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Sep 18;99(38):e22104. doi: 10.1097/MD.0000000000022104.
7
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.肝细胞癌的风险因素以及种族和民族差异评估。
JGH Open. 2020 Apr 15;4(3):351-359. doi: 10.1002/jgh3.12336. eCollection 2020 Jun.
8
Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years.吸烟对英国25种不同癌症发病风险的影响:一项对422,010名患者长达30年的随访回顾性研究。
Oncotarget. 2018 Apr 3;9(25):17420-17429. doi: 10.18632/oncotarget.24724.
9
Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas.吸烟习惯与病毒相关性肝细胞癌手术结局的相关性。
World J Gastroenterol. 2018 Jan 7;24(1):58-68. doi: 10.3748/wjg.v24.i1.58.
10
Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.吸烟习惯对接受根治性切除术的非B非C型肝细胞癌患者手术结局的影响。
World J Gastroenterol. 2017 Feb 28;23(8):1397-1405. doi: 10.3748/wjg.v23.i8.1397.